Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT06152133
Other study ID # 01
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date March 1, 2024
Est. completion date December 1, 2025

Study information

Verified date May 2024
Source Universitat de Lleida
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Hereditary ataxias (HA) are a heterogeneous group of degenerative diseases of the cerebellum, brain stem and spinal cord. People who suffer from AH, among other symptoms, present deficiencies in the stability of the trunk, which leads to an alteration in postural control, with a strongly influential factor in the loss of balance and gait disorders. Improving the functionality of these physical aspects can help reduce the rate of falls, increase autonomy and quality of life for people with HA. Evidence suggests that rehabilitation strategies based on core stability exercises (CSE) are effective in improving balance and postural control in several neurological diseases, such as stroke. However, there is little evidence with people with HA. In a previous study carried out by researchers of this project, in which an EEC exercise program was piloted at home, low adherence to treatment was perceived due to the little follow-up that was given to the participants. Therefore, including telerehabilitation in these programs would increase follow-up and could influence adherence.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 12
Est. completion date December 1, 2025
Est. primary completion date December 1, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Suffer from degenerative HA at any stage of the disease (Spinocerebellar ataxia, Friedreich's ataxia, sporadic idiopathic cerebellar ataxia and neurodegenerative diseases where ataxia is the dominant symptom). - Adults over 18 years of age. - Be able to use a computer or mobile phone (It will be evaluated using the DILE scale) - Have an internet connection. Exclusion Criteria: - Suffer from other neurological diseases and inability to follow simple instructions. - - Suffering from a musculoskeletal injury that prevents you from performing the exercises. - Being unable to maintain standing for more than 10 seconds without support (assessed with item 2 on the SARA scale).

Study Design


Intervention

Other:
Therapeutic core stability exercises
exercises focused on trunk muscle strengthening, proprioception, selective movements of the trunk and pelvis muscle, and coordination, and will be carried out in supine, sitting on a stable surface and sitting on an unstable surface (ball). The exercise involves changes in the position of the body with or without resistance, aiming to improve strength, endurance, proprioception and coordination. Training is determined by the patient's ability to undertake easy exercises and progress to more challenging exercises.

Locations

Country Name City State
Spain University of Lleida Lleida

Sponsors (3)

Lead Sponsor Collaborator
Universitat de Lleida Hospital Clinic of Barcelona, Universitat Internacional de Catalunya

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of dynamic sitting balance and trunk coordination panish-version of Trunk Impairment Scale 2.0. Each item will be performed three times and the highest score counts. Otherwise, no practice session allowed. The patient can be corrected between attempts. The tests are verbally explained to the patient and can be demonstrated if needed. There are two subscales: dynamic sitting balance and coordination. The first have 10 items and second 6. The highest possible total score is consequently 16 points, which indicates a good dynamic sitting balance and correct trunk control and sitting coordination. If the patient cannot maintain a sitting position for 10 seconds without back and arm support, with hands on thighs, feet in contact with the ground and knees bent at 90° (starting position), the total score for the scale is 0 points. T0: Baseline, T1: 7 weeks and T0: follow up 7 weeks
Primary Static sitting balance and Standing balance Static sitting balance will be recorded with the sitting section of SARA, standing balance will be recorded with the standing section of SARA as well, as well as walking. T0: Baseline, T1: 7 weeks and T0: follow up 7 weeks
Primary Walking Speed The walking speed will be determined with the 4 meter walking test. T0: Baseline, T1: 7 weeks and T0: follow up 7 weeks
Secondary ADLs ADLs will be assessed with the Activities-specific Balance Confidence (ABC) T0: Baseline, T1: 7 weeks and T0: follow up 7 weeks
Secondary Lower extremity strength Lower extremity strength will be assessed with the 30 s Sit-to-stand test. T0: Baseline, T1: 7 weeks and T0: follow up 7 weeks
Secondary Adherence to treatment Adherence to treatment will be asses with the Exercise Adherence Rating Scale (EARS) (Newman-Beinart 2017). T1: 7 weeks and T0: follow up 7 weeks
Secondary Risk of falls The risk of falls with the Timed Up and GO scale T0: Baseline, T1: 7 weeks and T0: follow up 7 weeks
Secondary Severity of ataxia The severity of ataxia will be evaluated with the SARA scale T0: Baseline, T1: 7 weeks and T0: follow up 7 weeks
Secondary Treatment compliance treatment compliance measured as the rate of sessions performed/prescribed (Capecci 2023), we will obtain the % compliance for each participant with the calculation Total number of minutes performed by the patient / Total number of minutes that should have been done (1400 minutes) x 100. Or with the calculation Total number of exercises per session performed by the patient / Total number of exercises that should have been done (23 per session) x 100 T1: 7 weeks and T0: follow up 7 weeks
Secondary Program satisfaction A questionnaire will be administered to participants to evaluate both their experience and satisfaction with the program, as well as its adverse effects. T1: 7 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04039048 - Effect of ctDCS During Balance Training on Cerebellar Ataxia N/A
Not yet recruiting NCT04054726 - A Study on Cerebello-Spinal tPCS in Ataxia N/A
Completed NCT02887703 - Augmenting Balance in Individuals With Cerebellar Ataxias N/A
Completed NCT02540655 - Efficacy and Safety Study of Stemchymal® in Polyglutamine Spinocerebellar Ataxia Phase 2
Recruiting NCT01958177 - Clinical Study to Evaluate the Safety and Efficacy BMMNC in Cerebellar Ataxia Phase 1/Phase 2
Recruiting NCT03972202 - The Role of Cerebellum in Speech N/A
Recruiting NCT03341416 - Effects of Deep Brain Stimulation of the Dentate Nucleus on Cerebellar Ataxia N/A
Completed NCT05095870 - Evaluation of the Peripheral Nerve Ultrasound as a Diagnostic Tool in CANVAS Neuropathies
Completed NCT04790981 - Effect of Motor Imagery Training on Ataxic Children After Medulloblastoma Resection N/A
Completed NCT02900508 - Virtual Reality-based Training in Cerebellar Ataxia N/A
Active, not recruiting NCT05024240 - Interaction of the Cognitive and Sensory-cognitive Tasks With Postural Stability in Individuals With Stability Disorders N/A
Completed NCT00006492 - Gluten-Free Diet in Patients With Gluten Sensitivity and Cerebellar Ataxia N/A
Completed NCT01649687 - Treatment of Cerebellar Ataxia With Mesenchymal Stem Cells Phase 1/Phase 2
Completed NCT04750850 - Core Stability Exercises and Hereditary Ataxia N/A
Active, not recruiting NCT05157802 - Promoting Physical Activity Engagement for People With Early-stage Cerebellar Ataxia Phase 1
Completed NCT05278091 - Evaluation of the Diagnostic Value of Video-oculography in CANVAS Neuronopathies
Completed NCT05436262 - Using Real-time fMRI Neurofeedback and Motor Imagery to Enhance Motor Timing and Precision in Cerebellar Ataxia N/A
Completed NCT04648501 - Dual Task Training for Cerebellar Ataxia N/A
Enrolling by invitation NCT03269201 - Brain Network Activation in Patients With Movement Disorders
Completed NCT00202397 - Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia Phase 2